Free shipping on all orders over $ 500

CP-376395

Cat. No. M9705
CP-376395 Structure
Synonym:

CP376395

Size Price Availability
10mg USD 217  USD217 4-7 Days
25mg USD 455  USD455 4-7 Days
50mg USD 876  USD876 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CP-376395 is a CRF1-selective antagonist. CP-376395 fully antagonizes oCRF-stimulated adenylate cyclase activity in rat cerebral cortex and at human CRF1 receptors with an apparent Ki value of 12 nM, indicating antagonist functional activity. In the CNS, systemically administered CP-376395 blocks the effects of both exogenous and endogenous CRF. CP-376395 treatment reverses the excitation of locus coeruleus neurons induced by icv CRF (3 µg) with an ID50 of completely blocked the enhanced startle response induced by icv CRF (1 µg) at 17.8 mg/kg, p.o. and partially blocked at 10 mg/kg, p.o. without significantly altering baseline startle.

Chemical Information
Molecular Weight 326.48
Formula C21H30N2O
CAS Number 175140-00-8
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] M P Faria, et al. Neuropharmacology. Anxiogenesis induced by social defeat in male mice: Role of nitric oxide, NMDA, and CRF 1 receptors in the medial prefrontal cortex and BNST

[2] Alan M Szalai, et al. Phys Chem Chem Phys. A fluorescence nanoscopy marker for corticotropin-releasing hormone type 1 receptor: computer design, synthesis, signaling effects, super-resolved fluorescence imaging, and in situ affinity constant in cells

[3] Emily L Newman, et al. Psychopharmacology (Berl). Persistent escalation of alcohol consumption by mice exposed to brief episodes of social defeat stress: suppression by CRF-R1 antagonism

[4] Fabrizio Sanna, et al. Horm Behav. Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: Involvement of glutamic acid, dopamine, and nitric oxide

[5] Leandro A Oliveira, et al. Eur J Neurosci. CRF 1 and CRF 2 receptors in the bed nucleus of stria terminalis differently modulate the baroreflex function in unanesthetized rats

Related CRFR Products
K41498 TFA

K41498 TFA is an antisauvagine-30 (aSvg-30) analog and a strongly selective CRF2 receptor antagonist with Ki values of 0.66 nM, 0.62 nM, and 425 nM for human CRF2α, CRF2β, and CRF1 receptors, respectively.K41498 TFA inhibits sauvagine-stimulated cAMP accumulation in hCRF2α/hCRF2β expressing cells. K41498 TFA can be used in hypotension studies.

Astressin 2B TFA

Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist with IC50 values of 1.3 and > 500 nM for CRF2 and CRF1, respectively.

Urocortin, rat

Urocortin, rat (Urocortin (Rattus norvegicus)) is a neuropeptide and a potent endogenous CRFR agonist with Kis of 13 nM, 1.5 nM, and 0.97 nM for human CRF1, rat CRF2α and mouse CRF2β, respectively.

Urocortin, human

Urocortin, human, a 40-aa neuropeptide, acts as a selective agonist of endogenous CRF2 receptor, with Kis of 0.4, 0.3, and 0.5 nM for hCRF1, rCRF2α and mCRF2β, respectively.

CRF(6-33)(human)

CRF(6-33)(human) is a CRF binding protein (CRF-BP) ligand inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: CP-376395, CP376395 supplier, CRFR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.